Severe Acute Respiratory Syndrome: Epidemiology, Pathogenesis, and Animal Models

John Nicholls; J. S. Malik Peiris; Stanley Perlman

doi:10.1128/9781555815790.ch19

Chapter 19 : Severe Acute Respiratory Syndrome: Epidemiology, Pathogenesis, and Animal Models

Authors: John Nicholls¹, J. S. Malik Peiris², Stanley Perlman³

VIEW AFFILIATIONS HIDE AFFILIATIONS

Affiliations: 1: Department of Pathology, The University of Hong Kong, Hong Kong Special Administrative Region, China; 2: Department of Microbiology, The University of Hong Kong, Hong Kong Special Administrative Region, China; 3: Department of Microbiology, University of Iowa, Iowa City, IA 52242

Content Type: Monograph

Publication Year: 2008

Category: Viruses and Viral Pathogenesis

Book DOI: 10.1128/9781555815790

Chapter DOI: 10.1128/9781555815790.ch19

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Preview this chapter:

Severe Acute Respiratory Syndrome: Epidemiology, Pathogenesis, and Animal Models, Page 1 of 2

< Previous page | Next page > /docserver/preview/fulltext/10.1128/9781555815790/9781555814557_Chap19-1.gif /docserver/preview/fulltext/10.1128/9781555815790/9781555814557_Chap19-2.gif

Abstract:

Quantitative studies on viral load in the upper respiratory tract and the feces of patients infected with severe acute respiratory syndrome-coronavirus (SARS-CoV) revealed a progressive increase in viral load, peaking around day 10 after onset of disease symptoms. This explains the epidemiological observation that transmission mainly occurs after the fifth day of illness. Clinical and pathological studies of SARS cases indicate that cells in the lower respiratory tract, particularly type 1 pneumocytes, are the prime targets of SARS, with macrophages subsequently being infected. Although angiotensin-converting enzyme 2 (ACE2) is the primary receptor for SARS, other receptors such as L-SIGN and DC-SIGN may facilitate virus infection, even under circumstances when the virus has not fully adapted to a new host. Epithelial lung damage together with macrophage activation results in increased levels of proinflammatory cytokines. The initial phase of lung disease exists for 10 to 14 days, after which many of the changes present can be attributed to the sequelae of diffuse lung damage, including the effects of mechanical ventilation. As with many other newly emerging infections, SARS had zoonotic origins, highlighting the need for a better understanding of the virus ecology of both wild and domestic animals. As many of these zoonoses do not cause disease in their natural host, surveillance needs to encompass viruses causing unobvious infections as well as those causing overt disease and will require the cooperation of multiple agencies, including those dealing with public health, veterinary medicine, and wildlife or the environment.

Citation: Nicholls J, Peiris J, Perlman S. 2008. Severe Acute Respiratory Syndrome: Epidemiology, Pathogenesis, and Animal Models, p 299-311. In Perlman S, Gallagher T, Snijder E (ed), Nidoviruses. ASM Press, Washington, DC. doi: 10.1128/9781555815790.ch19

Key Concept Ranking

Severe Acute Respiratory Syndrome: 0.47982648
Acute Respiratory Distress Syndrome: 0.46434826
Lower Respiratory Tract Infections: 0.42298073

0.47982648

Highlighted Text: Show | Hide

Full text loading...

Figures

Severe Acute Respiratory Syndrome: Epidemiology, Pathogenesis, and Animal Models

[com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/author/10.1128/9781555815790.ch19-1,webId=/content/author/10.1128/9781555815790.ch19-1,properties={foaf_givenname=John, foaf_name=John Nicholls, foaf_surname=Nicholls, pub_isAffiliatedWith=[com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/affiliation/10.1128/9781555815790.ch19-aff1]]}], com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/author/10.1128/9781555815790.ch19-2,webId=/content/author/10.1128/9781555815790.ch19-2,properties={foaf_givenname=J. S. Malik, foaf_name=J. S. Malik Peiris, foaf_surname=Peiris, pub_isAffiliatedWith=[com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/affiliation/10.1128/9781555815790.ch19-aff2]]}], com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/author/10.1128/9781555815790.ch19-3,webId=/content/author/10.1128/9781555815790.ch19-3,properties={foaf_givenname=Stanley, foaf_name=Stanley Perlman, foaf_surname=Perlman, pub_isAffiliatedWith=[com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/affiliation/10.1128/9781555815790.ch19-aff3]]}]]

/content/10.1128/9781555815790.ch19.ch19fig01

Figure 1.

Schematic of SARS-CoV infection. SARS-CoV is detected in pneumocytes and in alveolar macrophages (upper left panel). Infection of macrophages results in the secretion of proinflammatory cytokines and chemokines but not IFN-β. Expression of these factors results in tissue damage, increased inflammation, and lung damage, resulting in the nonspecific pulmonary findings observed in patients with SARS (middle panel). As part of the disease process, infected type 1 pneumocytes slough into alveolar spaces and airways; regeneration is evidenced by proliferation of type 2 pneumocytes. Multinucleated giant cells are also observed in SARS-CoV-infected lungs (lower panels). Normal lung tissue is also shown (upper right panel).

10.1128/9781555815790/f0306-01_thmb.gif

10.1128/9781555815790/f0306-01.gif

Figure 1.

References

/content/book/10.1128/9781555815790.ch19

1. Anand,, K.,, J. Ziebuhr,, P. Wadhwani,, J. R. Mesters, and, R. Hilgenfeld. 2003. Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs. Science 300: 1763– 1767.

2. Baas,, T.,, J. K. Taubenberger,, P. Y. Chong,, P. Chui,and, M. G. Katze. 2006. SARS-CoV virus-host interactions and comparative etiologies of acute respiratory distress syndrome as determined by transcriptional and cytokine profiling of formalin-fixed paraffin-embedded tissues. J. Interferon Cytokine Res. 26: 309– 317.

3. Booth, C. M.,, L. M. Matukas,, G. A. Tomlinson,, A. R. Rachlis,, D. B. Rose,, H. A. Dwosh,, S. L. Walmsley,, T. Mazzulli,, M. Avendano,, P. Derkach,, I. E. Ephtimios,, I. Kitai,, B. D. Mederski,, S. B. Shadowitz,, W. L. Gold,, L. A. Hawryluck,, E. Rea,, J. S. Chenkin,, D. W. Cescon,, S. M. Poutanen,and, A. S. Detsky. 2003. Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area. JAMA 289: 2801– 2809.

4. Chan, K. H.,, L. L. Poon,, V. C. Cheng,, Y. Guan,, I. F. Hung,, J. Kong,, L. Y. Yam,, W. H. Seto,, K. Y. Yuen,and, J. S. Peiris. 2004. Detection of SARS coronavirus in patients with suspected SARS. Emerg. Infect. Dis. 10: 294– 249.

5. Chan, P. K.,, J. W. Tang,and, D. S. Hui. 2006. SARS: clinical presentation, transmission, pathogenesis and treatment options. Clin. Sci. (London) 110: 193– 204.

6. Chan, V. S.,, K. Y. Chan,, Y. Chen,, L. L. Poon,, A. N. Cheung,, B. Zheng,, K. H. Chan,, W. Mak,, H. Y. Ngan,, X. Xu,, G. Screaton,, P. K. Tam,, J. M. Austyn,, L. C. Chan,, S. P. Yip,, M. Peiris,, U. S. Khoo,and, C. L. Lin. 2006. Homozygous L-SIGN (CLEC4M) plays a protective role in SARS coronavirus infection. Nat. Genet. 38: 38– 46.

7. Chan, W. S.,, C. Wu,, S. C. Chow,, T. Cheung,, K. F. To,, W. K. Leung,, P. K. Chan,, K. C. Lee,, H. K. Ng,, D. M. Au,and, A. W. Lo. 2005. Coronaviral hypothetical and structural proteins were found in the intestinal surface enterocytes and pneumocytes of severe acute respiratory syndrome (SARS). Mod. Pathol. 18: 1432– 1439.

8. Chau, T. N.,, P. O. Lee,, K. W. Choi,, C. M. Lee,, K. F. Ma,, T. Y. Tsang,, Y. K. Tso,, M. C. Chiu,, W. L. Tong,, W. C. Yu,and, S. T. Lai. 2004. Value of initial chest radiographs for predicting clinical outcomes in patients with severe acute respiratory syndrome. Am. J. Med. 117: 249– 254.

9. Cheng, P. K.,, D. A. Wong,, L. K. Tong,, S. M. Ip,, A. C. Lo,, C. S. Lau,, E. Y. Yeung,and, W. W. Lim. 2004. Viral shedding patterns of coronavirus in patients with probable severe acute respiratory syndrome. Lancet 363: 1699– 1700.

10. Cheung, C. Y.,, L. L. M. Poon,, I. H. Y. Ng,, W. Luk,, S.-F. Sia,, M. H. S. Wu,, K.-H. Chan,, K.-Y. Yuen,, S. Gordon,, Y. Guan,and, J. S. M. Peiris. 2005. Cytokine responses in severe acute respiratory syndrome coronavirus-infected macrophages in vitro: possible relevance to pathogenesis. J. Virol. 79: 7819– 7826.

11. Christian, M. D.,, S. M. Poutanen,, M. R. Loutfy,, M. P. Muller, and, D. E. Low. 2004. Severe acute respiratory syndrome. Clin. Infect. Dis. 38: 1420– 1427.

12. Chu, C. M.,, V. C. Cheng,, I. F. Hung,, K. S. Chan,, B. S. Tang,, T. H. Tsang,, K. H. Chan,and, K. Y. Yuen. 2005. Viral load distribution in SARS outbreak. Emerg. Infect. Dis. 11: 1882– 1886.

13. Chu, D. K.,, L. L. Poon,, K. H. Chan,, H. Chen,, Y. Guan,, K. Y. Yuen,and, J. S. Peiris. 2006. Coronaviruses in bent-winged bats (Miniopterus spp.). J. Gen. Virol. 87: 2461– 2466.

14. Cinatl, J., Jr.,, G. Hoever,, B. Morgenstern,, W. Preiser,, J. U. Vogel,, W. K. Hofmann,, G. Bauer,, M. Michaelis,, H. F. Rabenau, and, H. W. Doerr. 2004. Infection of cultured intestinal epithelial cells with severe acute respiratory syndrome coronavirus. Cell. Mol. Life Sci. 61: 2100– 2112.

15. Ding, Y.,, L. He,, Q. Zhang,, Z. Huang,, X. Che,, J. Hou,, H. Wang,, H. Shen,, L. Qiu,, Z. Li,, J. Geng,, J. Cai,, H. Han,, X. Li,, W. Kang,, D. Weng,, P. Liang, and, S. Jiang. 2004. Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways. J. Pathol. 203: 622– 630.

16. Ding, Y.,, H. Wang,, H. Shen,, Z. Li,, J. Geng,, H. Han,, J. Cai,, X. Li,, W. Kang,, D. Weng,, Y. Lu,, D. Wu,, L. He, and, K. Yao. 2003. The clinical pathology of severe acute respiratory syndrome (SARS): a report from China. J. Pathol. 200: 282– 289.

17. Drosten, C.,, S. Gunther,, W. Preiser,, S. van der Werf,, H. R. Brodt,, S. Becker,, H. Rabenau,, M. Panning,, L. Kolesnikova,, R. A. Fouchier,, A. Berger,, A. M. Burguiere,, J. Cinatl,, M. Eickmann,, N. Escriou,, K. Grywna,, S. Kramme,, J. C. Manuguerra,, S. Muller,, V. Rickerts,, M. Sturmer,, S. Vieth,, H. D. Klenk,, A. D. Osterhaus,, H. Schmitz,and, H. W. Doerr. 2003. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N. Engl. J. Med. 348: 1967– 1976.

18. Fan, C. K.,, K. M. Yieh,, M. Y. Peng,, J. C. Lin,, N. C. Wang,and, F. Y. Chang. 2006. Clinical and laboratory features in the early stage of severe acute respiratory syndrome. J. Microbiol. Immunol. Infect. 39: 45– 53.

19. Farcas, G. A.,, S. M. Poutanen,, T. Mazzulli,, B. M. Willey,, J. Butany,, S. L. Asa,, P. Faure,, P. Akhavan,, D. E. Low,and, K. C. Kain. 2005. Fatal severe acute respiratory syndrome is associated with multiorgan involvement by coronavirus. J. Infect. Dis. 191: 193– 197.

20. Fouchier, R. A.,, T. Kuiken,, M. Schutten,, G. van Amerongen,, G. J. van Doornum,, B. G. van den Hoogen,, M. Peiris,, W. Lim,, K. Stohr,and, A. D. Osterhaus. 2003. Aetiology: Koch’s postulates fulfilled for SARS virus. Nature 423: 240.

21. Franks, T. J.,, P. Y. Chong,, P. Chui,, J. R. Galvin,, R. M. Lourens,, A. H. Reid,, E. Selbs,, C. P. McEvoy,, C. D. Hayden,, J. Fukuoka,, J. K. Taubenberger,and, W. D. Travis. 2003. Lung pathology of severe acute respiratory syndrome (SARS): a study of 8 autopsy cases from Singapore. Hum. Pathol. 34: 743– 748.

22. Gu, J.,, E. Gong,, B. Zhang,, J. Zheng,, Z. Gao,, Y. Zhong,, W. Zou,, J. Zhan,, S. Wang,, Z. Xie,, H. Zhuang,, B. Wu,, H. Zhong,, H. Shao,, W. Fang,, D. Gao,, F. Pei,, X. Li,, Z. He,, D. Xu,, X. Shi,, V. M. Anderson,and, A. S. Leong. 2005. Multiple organ infection and the pathogenesis of SARS. J. Exp. Med. 202: 415– 424.

23. Guan, Y.,, J. S. Peiris,, B. Zheng,, L. L. Poon,, K. H. Chan,, F. Y. Zeng,, C. W. Chan,, M. N. Chan,, J. D. Chen,, K. Y. Chow,, C. C. Hon,, K. H. Hui,, J. Li,, V. Y. Li,, Y. Wang,, S. W. Leung,, K. Y. Yuen,and, F. C. Leung. 2004. Molecular epidemiology of the novel coronavirus that causes severe acute respiratory syndrome. Lancet 363: 99– 104.

24. Guan, Y.,, B. J. Zheng,, Y. Q. He,, X. L. Liu,, Z. X. Zhuang,, C. L. Cheung,, S. W. Luo,, P. H. Li,, L. J. Zhang,, Y. J. Guan,, K. M. Butt,, K. L. Wong,, K. W. Chan,, W. Lim,, K. F. Shortridge,, K. Y. Yuen,, J. S. Peiris,and, L. L. Poon. 2003. Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China. Science 302: 276– 278.

25. Haagmans, B. L.,, T. Kuiken,, B. E. Martina,, R. A. Fouchier,, G. F. Rimmelzwaan,, G. van Amerongen,, D. van Riel,, T. de Jong,, S. Itamura,, K. H. Chan,, M. Tashiro,and, A. D. Osterhaus. 2004. Pegylated interferon-alpha protects type 1 pneumocytes against SARS coronavirus infection in macaques. Nat. Med. 10: 290– 293.

26. Hamming, I.,, W. Timens,, M. L. Bulthuis,, A. T. Lely,, G. J. Navis, and, H. van Goor. 2004. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J. Pathol. 203: 631– 637.

27. Hung, I. F.,, V. C. Cheng,, A. K. Wu,, B. S. Tang,, K. H. Chan,, C. M. Chu,, M. M. Wong,, W. T. Hui,, L. L. Poon,, D. M. Tse,, K. S. Chan,, P. C. Woo,, S. K. Lau,, J. S. Peiris,and, K. Y. Yuen. 2004. Viral loads in clinical specimens and SARS manifestations. Emerg. Infect. Dis. 10: 1550– 1557.

28. Ip, W. K.,, K. H. Chan,, H. K. Law,, G. H. Tso,, E. K. Kong,, W. H. Wong,, Y. F. To,, R. W. Yung,, E. Y. Chow,, K. L. Au,, E. Y. Chan,, W. Lim,, J. C. Jensenius,, M. W. Turner,, J. S. Peiris,and, Y. L. Lau. 2005. Mannose-binding lectin in severe acute respiratory syndrome coronavirus infection. J. Infect. Dis. 191: 1697– 1704.

29. Jeffers, S. A.,, S. M. Tusell,, L. Gillim-Ross,, E. M. Hemmila,, J. E. Achenbach,, G. J. Babcock,, W. D. Thomas,, Jr., L. B. Thackray,, M. D. Young,, R. J. Mason,, D. M. Ambrosino,, D. E. Wentworth,, J. C. Demartini,and, K. V. Holmes. 2004. CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus. Proc. Natl. Acad. Sci. USA 101: 15748– 15753.

30. Jia, H. P.,, D. C. Look,, L. Shi,, M. Hickey,, L. Pewe,, J. Netland,, M. Farzan,, C. Wohlford-Lenane,, S. Perlman, and, P. B. McCray, Jr. 2005. ACE2 receptor expression and severe acute respiratory syndrome coronavirus infection depend on differentiation of human airway epithelia. J. Virol. 79: 14614– 14621.

31. Jiang, Y.,, J. Xu,, C. Zhou,, Z. Wu,, S. Zhong,, J. Liu,, W. Luo,, T. Chen,, Q. Qin, and, P. Deng. 2005. Characterization of cytokine and chemokine profiles of severe acute respiratory syndrome. Am. J. Respir. Crit. Care Med. 171: 850– 857.

32. Jones, B. M.,, E. S. Ma,, J. S. Peiris,, P. C. Wong,, J. C. Ho,, B. Lam,, K. N. Lai,and, K. W. Tsang. 2004. Prolonged disturbances of in vitro cytokine production in patients with severe acute respiratory syndrome (SARS) treated with ribavirin and steroids. Clin. Exp. Immunol. 135: 467– 473.

33. Kan, B.,, M. Wang,, H. Jing,, H. Xu,, X. Jiang,, M. Yan,, W. Liang,, H. Zheng,, K. Wan,, Q. Liu,, B. Cui,, Y. Xu,, E. Zhang,, H. Wang,, J. Ye,, G. Li,, M. Li,, Z. Cui,, X. Qi,, K. Chen,, L. Du,, K. Gao,, Y. T. Zhao,, X. Z. Zou,, Y. J. Feng,, Y. F. Gao,, R. Hai,, D. Yu,, Y. Guan, and, J. Xu. 2005. Molecular evolution analysis and geographic investigation of severe acute respiratory syndrome coronavirus-like virus in palm civets at an animal market and on farms. J. Virol. 79: 11892– 11900.

34. Ksiazek, T. G.,, D. Erdman,, C. S. Goldsmith,, S. R. Zaki,, T. Peret,, S. Emery,, S. Tong,, C. Urbani,, J. A. Comer,, W. Lim,, P. E. Rollin,, S. F. Dowell,, A. E. Ling,, C. D. Humphrey,, W. J. Shieh,, J. Guarner,, C. D. Paddock,, P. Rota,, B. Fields,, J. DeRisi,, J. Y. Yang,, N. Cox,, J. M. Hughes,, J. W. LeDuc,, W. J. Bellini,and, L. J. Anderson. 2003. A novel coronavirus associated with severe acute respiratory syndrome. N. Engl. J. Med. 348: 1953– 1966.

35. Kuba, K.,, Y. Imai,, S. Rao,, H. Gao,, F. Guo,, B. Guan,, Y. Huan,, P. Yang,, Y. Zhang,, W. Deng,, L. Bao,, B. Zhang,, G. Liu,, Z. Wang,, M. Chappell,, Y. Liu,, D. Zheng,, A. Leibbrandt,, T. Wada,, A. S. Slutsky,, D. Liu,, C. Qin,, C. Jiang,and, J. M. Penninger. 2005. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nat. Med. 11: 875– 879.

36. Kuiken, T.,, R. A. Fouchier,, M. Schutten,, G. F. Rimmelzwaan,, G. van Amerongen,, D. van Riel,, J. D. Laman,, T. de Jong,, G. van Doornum,, W. Lim,, A. E. Ling,, P. K. Chan,, J. S. Tam,, M. C. Zambon,, R. Gopal,, C. Drosten,, S. van der Werf,, N. Escriou,, J. C. Manuguerra,, K. Stohr,, J. S. Peiris,and, A. D. Osterhaus. 2003. Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome. Lancet 362: 263– 270.

37. Kuiken, T.,, F. A. Leighton,, R. A. Fouchier,, J. W. LeDuc,, J. S. Peiris,, A. Schudel,, K. Stohr,and, A. D. Osterhaus. 2005. Public health. Pathogen surveillance in animals. Science 309: 1680– 1681.

38. Lau, S. K.,, P. C. Woo,, K. S. Li,, Y. Huang,, H. W. Tsoi,, B. H. Wong,, S. S. Wong,, S. Y. Leung,, K. H. Chan,and, K. Y. Yuen. 2005. Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats. Proc. Natl. Acad. Sci. USA 102: 14040– 14045.

39. Law, H. K.,, C. Y. Cheung,, H. Y. Ng,, S. F. Sia,, Y. O. Chan,, W. Luk,, J. M. Nicholls,, J. S. Peiris,and, Y. L. Lau. 2005. Chemokine upregulation in SARS coronavirus infected human monocyte derived dendritic cells. Blood 106: 2366– 2376.

40. Lawler, J. V.,, T. P. Endy,, L. E. Hensley,, A. Garrison,, E. A. Fritz,, M. Lesar,, R. S. Baric,, D. A. Kulesh,, D. A. Norwood,, L. P. Wasieloski,, M. P. Ulrich,, T. R. Slezak,, E. Vitalis,, J. W. Huggins,, P. B. Jahrling, and, J. Paragas. 2006. Cynomolgus macaque as an animal model for severe acute respiratory syndrome. PLoS Med. 3: e149.

41. Lee, H. K.,, E. Y. Tso,, T. N. Chau,, O. T. Tsang,, K. W. Choi,and, T. S. Lai. 2003. Asymptomatic severe acute respiratory syndrome-associated coronavirus infection. Emerg. Infect. Dis. 9: 1491– 1492.

42. Lee, N.,, D. Hui,, A. Wu,, P. Chan,, P. Cameron,, G. M. Joynt,, A. Ahuja,, M. Y. Yung,, C. B. Leung,, K. F. To,, S. F. Lui,, C. C. Szeto,, S. Chung,and, J. J. Sung. 2003. A major outbreak of severe acute respiratory syndrome in Hong Kong. N. Engl. J. Med. 348: 1986– 1994.

43. Leung, C. W.,, Y. W. Kwan,, P. W. Ko,, S. S. Chiu,, P. Y. Loung,, N. C. Fong,, L. P. Lee,, Y. W. Hui,, H. K. Law,, W. H. Wong,, K. H. Chan,, J. S. Peiris,, W. W. Lim,, Y. L. Lau,and, M. C. Chiu. 2004. Severe acute respiratory syndrome among children. Pediatrics 113: e535– e543.

44. Leung, D. T.,, F. C. Tam,, C. H. Ma,, P. K. Chan,, J. L. Cheung,, H. Niu,, J. S. Tam,and, P. L. Lim. 2004. Antibody response of patients with severe acute respiratory syndrome (SARS) targets the viral nucleocapsid. J. Infect. Dis. 190: 379– 386.

45. Leung, D. T.,, W. W. van Maren,, F. K. Chan,, W. S. Chan,, A. W. Lo,, C. H. Ma,, F. C. Tam,, K. F. To,, P. K. Chan,, J. J. Sung,and, P. L. Lim. 2006. Extremely low exposure of a community to severe acute respiratory syndrome coronavirus: false seropositivity due to use of bacterially derived antigens. J. Virol. 80: 8920– 8928.

46. Li, F.,, W. Li,, M. Farzan,and, S. C. Harrison. 2005. Structure of SARS coronavirus spike receptor-binding domain complexed with receptor. Science 309: 1864– 1868.

47. Li, W.,, M. J. Moore,, N. Vasilieva,, J. Sui,, S. K. Wong,, M. A. Berne,, M. Somasundaran,, J. L. Sullivan,, K. Luzuriaga,, T. C. Greenough,, H. Choe, and, M. Farzan. 2003. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 426: 450– 454.

48. Li, W.,, Z. Shi,, M. Yu,, W. Ren,, C. Smith,, J. H. Epstein,, H. Wang,, G. Crameri,, Z. Hu,, H. Zhang,, J. Zhang,, J. McEachern,, H. Field,, P. Daszak,, B. T. Eaton,, S. Zhang,and, L. F. Wang. 2005. Bats are natural reservoirs of SARS-like coronaviruses. Science 310: 676– 679.

49. Li, W.,, C. Zhang,, J. Sui,, J. H. Kuhn,, M. J. Moore,, S. Luo,, S. K. Wong,, I. C. Huang,, K. Xu,, N. Vasilieva,, A. Murakami,, Y. He,, W. A. Marasco,, Y. Guan,, H. Choe, and, M. Farzan. 2005. Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2. EMBO J. 24: 1634– 1643.

50. Lipsitch, M.,, T. Cohen,, B. Cooper,, J. M. Robins,, S. Ma,, L. James,, G. Gopalakrishna,, S. K. Chew,, C. C. Tan,, M. H. Samore,, D. Fisman, and, M. Murray. 2003. Transmission dynamics and control of severe acute respiratory syndrome. Science 300: 1966– 1970.

51. Lu, Y. T.,, P. J. Chen,, C. Y. Sheu,and, C. L. Liu. 2006. Viral load and outcome in SARS infection: the role of personal protective equipment in the emergency department. J. Emerg. Med. 30: 7– 15.

52. Marra, M. A.,, S. J. Jones,, C. R. Astell,, R. A. Holt,, A. Brooks-Wilson,, Y. S. Butterfield,, J. Khattra,, J. K. Asano,, S. A. Barber,, S. Y. Chan,, A. Cloutier,, S. M. Coughlin,, D. Freeman,, N. Girn,, O. L. Griffith,, S. R. Leach,, M. Mayo,, H. McDonald,, S. B. Montgomery,, P. K. Pandoh,, A. S. Petrescu,, A. G. Robertson,, J. E. Schein,, A. Siddiqui,, D. E. Smailus,, J. M. Stott,, G. S. Yang,, F. Plummer,, A. Andonov,, H. Artsob,, N. Bastien,, K. Bernard,, T. F. Booth,, D. Bowness,, M. Czub,, M. Drebot,, L. Fernando,, R. Flick,, M. Garbutt,, M. Gray,, A. Grolla,, S. Jones,, H. Feldmann,, A. Meyers,, A. Kabani,, Y. Li,, S. Normand,, U. Stroher,, G. A. Tipples,, S. Tyler,, R. Vogrig,, D. Ward,, B. Watson,, R. C. Brunham,, M. Krajden,, M. Petric,, D. M. Skowronski,, C. Upton,and, R. L. Roper. 2003. The genome sequence of the SARS-associated coronavirus. Science 300: 1399– 1404.

53. McAuliffe, J.,, L. Vogel,, A. Roberts,, G. Fahle,, S. Fischer,, W. J. Shieh,, E. Butler,, S. Zaki,, M. St.-Claire,, B. Murphy, and, K. Subbarao. 2004. Replication of SARS coronavirus administered into the respiratory tract of African green, rhesus and cynomolgus monkeys. Virology 330: 8– 15.

54. Ng, M. H.,, K. M. Lau,, L. Li,, S. H. Cheng,, W. Y. Chan,, P. K. Hui,, B. Zee,, C. B. Leung,and, J. J. Sung. 2004. Association of human-leukocyte-antigen class I (B*0703) and class II (DRB1*0301) genotypes with susceptibility and resistance to the development of severe acute respiratory syndrome. J. Infect. Dis. 190: 515– 518.

55. Nicholls, J. M.,, J. Butany,, L. L. Poon,, K. H. Chan,, S. L. Beh,, S. Poutanen,, J. S. Peiris, and, M. Wong. 2006. Time course and cellular localization of SARS-CoV nucleoprotein and RNA in lungs from fatal cases of SARS. PLoS Med. 3: e27.

56. Nicholls, J. M.,, L. L. Poon,, K. C. Lee,, W. F. Ng,, S. T. Lai,, C. Y. Leung,, C. M. Chu,, P. K. Hui,, K. L. Mak,, W. Lim,, K. W. Yan,, K. H. Chan,, N. C. Tsang,, Y. Guan,, K. Y. Yuen,and, J. S. Peiris. 2003. Lung pathology of fatal severe acute respiratory syndrome. Lancet 361: 1773– 1778.

57. Nie, Y.,, G. Wang,, X. Shi,, H. Zhang,, Y. Qiu,, Z. He,, W. Wang,, G. Lian,, X. Yin,, L. Du,, L. Ren,, J. Wang,, X. He,, T. Li,, H. Deng, and, M. Ding. 2004. Neutralizing antibodies in patients with severe acute respiratory syndrome-associated coronavirus infection. J. Infect. Dis. 190: 1119– 1126.

58. Ong, K. C.,, A. W. Ng,, L. S. Lee,, G. Kaw,, S. K. Kwek,, M. K. Leow,and, A. Earnest. 2004. Pulmonary function and exercise capacity in survivors of severe acute respiratory syndrome. Eur. Respir. J. 24: 436– 442.

59. Peiris, J. S.,, C. M. Chu,, V. C. Cheng,, K. S. Chan,, I. F. Hung,, L. L. Poon,, K. I. Law,, B. S. Tang,, T. Y. Hon,, C. S. Chan,, K. H. Chan,, J. S. Ng,, B. J. Zheng,, W. L. Ng,, R. W. Lai,, Y. Guan,and, K. Y. Yuen. 2003. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet 361: 1767– 1772.

60. Peiris, J. S.,, Y. Guan,and, K. Y. Yuen. 2004. Severe acute respiratory syndrome. Nat. Med. 10: S88– S97.

61. Peiris, J. S.,, S. T. Lai,, L. L. Poon,, Y. Guan,, L. Y. Yam,, W. Lim,, J. Nicholls,, W. K. Yee,, W. W. Yan,, M. T. Cheung,, V. C. Cheng,, K. H. Chan,, D. N. Tsang,, R. W. Yung,, T. K. Ng,and, K. Y. Yuen. 2003. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet 361: 1319– 1325.

62. Peiris, J. S.,, K. Y. Yuen,, A. D. Osterhaus,and, K. Stohr. 2003. The severe acute respiratory syndrome. N. Engl. J. Med. 349: 2431– 2441.

63. Perlman, S., and A. A. Dandekar. 2005. Immunopathogenesis of coronavirus infections: implications for SARS. Nat. Rev. Immunol. 5: 917– 927.

64. Poon, L. L.,, D. K. Chu,, K. H. Chan,, O. K. Wong,, T. M. Ellis,, Y. H. Leung,, S. K. Lau,, P. C. Woo,, K. Y. Suen,, K. Y. Yuen,, Y. Guan, and, J. S. Peiris. 2005. Identification of a novel coronavirus in bats. J. Virol. 79: 2001– 2009.

65. Poutanen, S. M.,, D. E. Low,, B. Henry,, S. Finkelstein,, D. Rose,, K. Green,, R. Tellier,, R. Draker,, D. Adachi,, M. Ayers,, A. K. Chan,, D. M. Skowronski,, I. Salit,, A. E. Simor,, A. S. Slutsky,, P. W. Doyle,, M. Krajden,, M. Petric,, R. C. Brunham, and, A. J. McGeer. 2003. Identification of severe acute respiratory syndrome in Canada. N. Engl. J. Med. 348: 1995– 2005.

66. Ratia, K.,, K. S. Saikatendu,, B. D. Santarsiero,, N. Barretto,, S. C. Baker,, R. C. Stevens,and, A. D. Mesecar. 2006. Severe acute respiratory syndrome coronavirus papain-like protease: structure of a viral deubiquitinating enzyme. Proc. Natl. Acad. Sci. USA 103: 5717– 5722.

67. Ren, X.,, J. Glende,, M. Al-Falah,, V. de Vries,, C. Schwegmann-Wessels,, X. Qu,, L. Tan,, T. Tschernig,, H. Deng,, H. Y. Naim,and, G. Herrler. 2006. Analysis of ACE2 in polarized epithelial cells: surface expression and function as receptor for severe acute respiratory syndrome-associated coronavirus. J. Gen. Virol. 87: 1691– 1965.

68. Riley, S.,, C. Fraser,, C. A. Donnelly,, A. C. Ghani,, L. J. AbuRaddad,, A. J. Hedley,, G. M. Leung,, L. M. Ho,, T. H. Lam,, T. Q. Thach,, P. Chau,, K. P. Chan,, S. V. Lo,, P. Y. Leung,, T. Tsang,, W. Ho,, K. H. Lee,, E. M. Lau,, N. M. Ferguson,and, R. M. Anderson. 2003. Transmission dynamics of the etiological agent of SARS in Hong Kong: impact of public health interventions. Science 300: 1961– 1966.

69. Roberts, A.,, L. Vogel,, J. Guarner,, N. Hayes,, B. Murphy,, S. Zaki,and, K. Subbarao. 2005. Severe acute respiratory syndrome coronavirus infection of golden Syrian hamsters. J. Virol. 79: 503– 511.

70. Rota, P. A.,, M. S. Oberste,, S. S. Monroe,, W. A. Nix,, R. Campagnoli,, J. P. Icenogle,, S. Penaranda,, B. Bankamp,, K. Maher,, M. H. Chen,, S. Tong,, A. Tamin,, L. Lowe,, M. Frace,, J. L. DeRisi,, Q. Chen,, D. Wang,, D. D. Erdman,, T. C. Peret,, C. Burns,, T. G. Ksiazek,, P. E. Rollin,, A. Sanchez,, S. Liffick,, B. Holloway,, J. Limor,, K. McCaustland,, M. Olsen-Rasmussen,, R. Fouchier,, S. Gunther,, A. D. Osterhaus,, C. Drosten,, M. A. Pallansch,, L. J. Anderson,and, W. J. Bellini. 2003. Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science 300: 1394– 1399.

71. Shih, Y. P.,, C. Y. Chen,, S. J. Liu,, K. H. Chen,, Y. M. Lee,, Y. C. Chao,and, Y. M. Chen. 2006. Identifying epitopes responsible for neutralizing antibody and DC-SIGN binding on the spike glycoprotein of the severe acute respiratory syndrome corona-virus. J. Virol. 80: 10315– 10324.

72. Simmons, G.,, J. D. Reeves,, A. J. Rennekamp,, S. M. Amberg,, A. J. Piefer,and, P. Bates. 2004. Characterization of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spike glycoprotein-mediated viral entry. Proc. Natl. Acad. Sci. USA 101: 4240– 4250.

73. Sims, A. C.,, R. S. Baric,, B. Yount,, S. E. Burkett,, P. L. Collins,and, R. J. Pickles. 2005. Severe acute respiratory syndrome coronavirus infection of human ciliated airway epithelia: role of ciliated cells in viral spread in the conducting airways of the lungs. J. Virol. 79: 15511– 15524.

74. Snijder, E. J.,, P. J. Bredenbeek,, J. C. Dobbe,, V. Thiel,, J. Ziebuhr,, L. L. Poon,, Y. Guan,, M. Rozanov,, W. J. Spaan,and, A. E. Gorbalenya. 2003. Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 lineage. J. Mol. Biol. 331: 991– 1004.

75. Song, H. D.,, C. C. Tu,, G. W. Zhang,, S. Y. Wang,, K. Zheng,, L. C. Lei,, Q. X. Chen,, Y. W. Gao,, H. Q. Zhou,, H. Xiang,, H. J. Zheng,, S. W. Chern,, F. Cheng,, C. M. Pan,, H. Xuan,, S. J. Chen,, H. M. Luo,, D. H. Zhou,, Y. F. Liu,, J. F. He,, P. Z. Qin,, L. H. Li,, Y. Q. Ren,, W. J. Liang,, Y. D. Yu,, L. Anderson,, M. Wang,, R. H. Xu,, X. W. Wu,, H. Y. Zheng,, J. D. Chen,, G. Liang,, Y. Gao,, M. Liao,, L. Fang,, L. Y. Jiang,, H. Li,, F. Chen,, B. Di,, L. J. He,, J. Y. Lin,, S. Tong,, X. Kong,, L. Du,, P. Hao,, H. Tang,, A. Bernini,, X. J. Yu,, O. Spiga,, Z. M. Guo,, H. Y. Pan,, W. Z. He,, J. C. Manuguerra,, A. Fontanet,, A. Danchin,, N. Niccolai,, Y. X. Li,, C. I. Wu,and, G. P. Zhao. 2005. Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human. Proc. Natl. Acad. Sci. USA 102: 2430– 2435.

76. Spiegel, M.,, A. Pichlmair,, L. Martinez-Sobrido,, J. Cros,, A. Garcia-Sastre,, O. Haller,and, F. Weber. 2005. Inhibition of beta interferon induction by severe acute respiratory syndrome coronavirus suggests a two-step model for activation of interferon regulatory factor 3. J. Virol. 79: 2079– 2086.

77. Stockman, L. J.,, R. Bellamy,and, P. Garner. 2006. SARS: systematic review of treatment effects. PLoS Med. 3: e343.

78. Subbarao, K., and A. Roberts. 2006. Is there an ideal animal model for SARS? Trends Microbiol. 14: 299– 303.

79. Tang, X. C.,, J. X. Zhang,, S. Y. Zhang,, P. Wang,, X. H. Fan,, L. F. Li,, G. Li,, B. Q. Dong,, W. Liu,, C. L. Cheung,, K. M. Xu,, W. J. Song,, D. Vijaykrishna,, L. L. Poon,, J. S. Peiris,, G. J. Smith,, H. Chen,and, Y. Guan. 2006. Prevalence and genetic diversity of coronaviruses in bats from China. J. Virol. 80: 7481– 7490.

80. To, K. F., and, A. W. Lo. 2004. Exploring the pathogenesis of severe acute respiratory syndrome (SARS): the tissue distribution of the coronavirus (SARS-CoV) and its putative receptor, angiotensin-converting enzyme 2 (ACE2). J. Pathol. 203: 740– 743.

81. Tsang, K. W.,, P. L. Ho,, G. C. Ooi,, W. K. Yee,, T. Wang,, M. Chan-Yeung,, W. K. Lam,, W. H. Seto,, L. Y. Yam,, T. M. Cheung,, P. C. Wong,, B. Lam,, M. S. Ip,, J. Chan,, K. Y. Yuen,and, K. N. Lai. 2003. A cluster of cases of severe acute respiratory syndrome in Hong Kong. N. Engl. J. Med. 348: 1977– 1985.

82. Tseng, C. T.,, L. A. Perrone,, H. Zhu,, S. Makino,and, C. J. Peters. 2005. Severe acute respiratory syndrome and the innate immune responses: Modulation of effector cell function without productive infection. J. Immunol. 174: 7977– 7985.

83. Tu, C.,, G. Crameri,, X. Kong,, J. Chen,, Y. Sun,, M. Yu,, H. Xiang,, X. Xia,, S. Liu,, T. Ren,, Y. Yu,, B. T. Eaton,, H. Xuan,and, L. F. Wang. 2004. Antibodies to SARS coronavirus in civets. Emerg. Infect. Dis. 10: 2244– 2248.

84. Wang, Y. D.,, W. Y. Sin,, G. B. Xu,, H. H. Yang,, T. Y. Wong,, X. W. Pang,, X. Y. He,, H. G. Zhang,, J. N. Ng,, C. S. Cheng,, J. Yu,, L. Meng,, R. F. Yang,, S. T. Lai,, Z. H. Guo,, Y. Xie,and, W. F. Chen. 2004. T-cell epitopes in severe acute respiratory syndrome (SARS) coronavirus spike protein elicit a specific T-cell immune response in patients who recover from SARS. J. Virol. 78: 5612– 5618.

85. Weiss, S. R., and, S. Navas-Martin. 2005. Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus. Microbiol. Mol. Biol. Rev. 69: 635– 664.

86. 84a Wong, C. K.,, C. W. Lam,, A. K. Wu,, W. K. Ip,, N. L. Lee,, I. H. Chan,, L. C. Lit,, D. S. Hui,, M. H. Chan,, S. S. Chung, and, J. J. Sung. 2004. Plasma inflammatory cytokines and chemokines in severe respiratory syndrome. Clin. Exp. Immunol. 136: 95– 103.

87. Wong, R. S.,, A. Wu,, K. F. To,, N. Lee,, C. W. Lam,, C. K. Wong,, P. K. Chan,, M. H. Ng,, L. M. Yu,, D. S. Hui,, J. S. Tam,, G. Cheng,and, J. J. Sung. 2003. Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis. BMJ 326: 1358– 1362.

88. Woo, P. C.,, S. K. Lau,, K. S. Li,, R. W. Poon,, B. H. Wong,, H. W. Tsoi,, B. C. Yip,, Y. Huang,, K. H. Chan,and, K. Y. Yuen. 2006. Molecular diversity of coronaviruses in bats. Virology 351: 180– 187.

89. World Health Organization Multicentre Collaborative Network for Severe Acute Respiratory Syndrome Diagnosis. 2003. A multicentre collaboration to investigate the cause of severe acute respiratory syndrome. Lancet 361: 1730– 1733.

90. Wu, D.,, C. Tu,, C. Xin,, H. Xuan,, Q. Meng,, Y. Liu,, Y. Yu,, Y. Guan,, Y. Jiang,, X. Yin,, G. Crameri,, M. Wang,, C. Li,, S. Liu,, M. Liao,, L. Feng,, H. Xiang,, J. Sun,, J. Chen,, Y. Sun,, S. Gu,, N. Liu,, D. Fu,, B. T. Eaton,, L. F. Wang,and, X. Kong. 2005. Civets are equally susceptible to experimental infection by two different severe acute respiratory syndrome coronavirus isolates. J. Virol. 79: 2620– 2625.

91. Xu, J.,, S. Zhong,, J. Liu,, L. Li,, Y. Li,, X. Wu,, Z. Li,, P. Deng,, J. Zhang,, N. Zhong,, Y. Ding,and, Y. Jiang. 2005. Detection of severe acute respiratory syndrome coronavirus in the brain: potential role of the chemokine Mig in pathogenesis. Clin. Infect. Dis. 41: 1089– 1096.

92. Xu, R. H.,, J. F. He,, M. R. Evans,, G. W. Peng,, H. E. Field,, D. W. Yu,, C. K. Lee,, H. M. Luo,, W. S. Lin,, P. Lin,, L. H. Li,, W. J. Liang,, J. Y. Lin,and, A. Schnur. 2004. Epidemiologic clues to SARS origin in China. Emerg. Infect. Dis. 10: 1030– 1037.

93. Yamashita, M.,, M. Yamate,, G. M. Li,and, K. Ikuta. 2005. Susceptibility of human and rat neural cell lines to infection by SARS-coronavirus. Biochem. Biophys. Res. Commun. 334: 79– 85.

94. Yang, Z. Y.,, Y. Huang,, L. Ganesh,, K. Leung,, W. P. Kong,, O. Schwartz,, K. Subbarao,and, G. J. Nabel. 2004. pH-dependent entry of severe acute respiratory syndrome coronavirus is mediated by the spike glycoprotein and enhanced by dendritic cell transfer through DC-SIGN. J. Virol. 78: 5642– 5650.

95. Yang, Z. Y.,, H. C. Werner,, W. P. Kong,, K. Leung,, E. Traggiai,, A. Lanzavecchia,and, G. J. Nabel. 2005. Evasion of antibody neutralization in emerging severe acute respiratory syndrome coronaviruses. Proc. Natl. Acad. Sci. USA 102: 797– 801.

96. Yeh, S. H.,, H. Y. Wang,, C. Y. Tsai,, C. L. Kao,, J. Y. Yang,, H. W. Liu,, I. J. Su,, S. F. Tsai,, D. S. Chen,and, P. J. Chen. 2004. Characterization of severe acute respiratory syndrome corona-virus genomes in Taiwan: molecular epidemiology and genome evolution. Proc. Natl. Acad. Sci. USA 101: 2542– 2547.

97. Yount, B.,, R. S. Roberts,, L. Lindesmith,and, R. S. Baric. 2006. Rewiring the severe acute respiratory syndrome coronavirus (SARS-CoV) transcription circuit: engineering arecombination-resistant genome. Proc. Natl. Acad. Sci. USA 103: 12546– 12551.

98. Yu, C. M.,, R. S. Wong,, E. B. Wu,, S. L. Kong,, J. Wong,, G. W. Yip,, Y. O. Soo,, M. L. Chiu,, Y. S. Chan,, D. Hui,, N. Lee,, A. Wu,, C. B. Leung,and, J. J. Sung. 2006. Cardiovascular complications of severe acute respiratory syndrome. Postgrad. Med. J. 82: 140– 144.

99. Zeng, F. Y.,, C. W. Chan,, M. N. Chan,, J. D. Chen,, K. Y. Chow,, C. C. Hon,, K. H. Hui,, J. Li,, V. Y. Li,, C. Y. Wang,, P. Y. Wang,, Y. Guan,, B. Zheng,, L. L. Poon,, K. H. Chan,, K. Y. Yuen,, J. S. Peiris,and, F. C. Leung. 2003. The complete genome sequence of severe acute respiratory syndrome coronavirus strain HKU-39849 (HK-39). Exp. Biol. Med. (Maywood) 228: 866– 873.

100. Zhou, M.,, D. Xu,, X. Li,, H. Li,, M. Shan,, J. Tang,, M. Wang,, F. S. Wang,, X. Zhu,, H. Tao,, W. He,, P. Tien,and, G. F. Gao. 2006. Screening and identification of severe acute respiratory syndrome-associated coronavirus-specific CTL epitopes. J. Immunol. 177: 2138– 2145.